Tissue Engineering Products.

CardioCel® is an adapted collagen cardiovascular scaffold. It is the first of a suite of implantable tissues generated by our ADAPT® tissue engineering process, which offers medical professionals a potential improvement over the products they currently use.
This product is changing patients’ lives across the world. Surgeons at medical centres throughout Europe, the US, Australia and Singapore are using CardioCel®, giving hope to patients with heart defects and those in need of heart valve, vessel and cardiovascular repairs.

CardioCel® also has licensing approval in Canada.

This product also has the potential to treat other conditions which benefit from the use of a tissue scaffold.

Manufactured to the highest international standards at our bio-manufacturing facility in Perth, Western Australia, CardioCel® is making a difference to patients and their families.